Eurofins Scientific SE

Major Shareholding Notification • Jan 12, 2026

{0}------------------------------------------------

Director/PDMR Shareholding

12 January 2026

Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.	Details of the person discharging managerial responsibilities/person closely associated
		Analytical	Bioventures	S.C.A	(RCS	B89265)
a)	Name	23, Va Fleuri, L-1526 Luxembourg

2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial

3.		Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57

4.		Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
		Acquisition of shares
b)	Nature of the transaction
		Price(s)	Volume(s)
c)	Price(s) and volume(s)	EUR 68.052700	1000
	Aggregated information
	— Aggregated volume	1000
d)	— Price	EUR 68,052.70
e)	Date of the transaction	2026-01-06
f)	Place of the transaction	XPAR

{1}------------------------------------------------

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.	Details of the person discharging managerial responsibilities/person closely associated
		Analytical	Bioventures	S.C.A	(RCS	B89265)
a)	Name		23, Va Fleuri, L-1526 Luxembourg

2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial

3.
a)	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Name Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57

4.		Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
		Acquisition of shares
b)	Nature of the transaction
		Price(s)	Volume(s)
c)	Price(s) and volume(s)	EUR 68.834400	1000
	Aggregated information
	— Aggregated volume	1000
d)	— Price	EUR 68,834.40
e)	Date of the transaction	2026-01-07
f)	Place of the transaction	XPAR

{2}------------------------------------------------

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.	Details of the person discharging managerial responsibilities/person closely associated
		Analytical	Bioventures	S.C.A	(RCS	B89265)
a)	Name		23, Va Fleuri, L-1526 Luxembourg

2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial

3.		Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57

4.	Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
		Acquisition of shares
b)	Nature of the transaction
		Price(s)	Volume(s)
c)	Price(s) and volume(s)	EUR 68.844100	1000
	Aggregated information
	— Aggregated volume	1000
d)	— Price	EUR 68,844.10
e)	Date of the transaction	2026-01-08
f)	Place of the transaction	XPAR

{3}------------------------------------------------

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.	Details of the person discharging managerial responsibilities/person closely associated
		Analytical	Bioventures	S.C.A	(RCS	B89265)
a)	Name		23, Va Fleuri, L-1526 Luxembourg

2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial

3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57

4.	Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
		Acquisition of shares
b)	Nature of the transaction
		Price(s)	Volume(s)
c)	Price(s) and volume(s)	EUR 69.593200	1000
	Aggregated information
	— Aggregated volume	1000
d)	— Price	EUR 69,593.20
e)	Date of the transaction	2026-01-09
f)	Place of the transaction	XPAR

For more information, please visit www.eurofins.com or contact:

Investor Relations Eurofins Scientific SE Phone: +32 2 766 1620 E-mail: ir@sc.eurofinseu.com

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With ca. 63,000 staff across a network of more than 950 laboratories in over 1,000 companies in 60 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.